Developer docs
API playgroundTry for free, no card

Search company profiles

Cold-EEZE

Full company profile

uuid000eryg

Namestring
Cold-EEZE
Legal namestring
Vespyr Brands, Inc.
Websiteurl
coldeeze.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Cold-EEZE is a US-based consumer health brand that manufactures and markets homeopathic cold-shortening lozenges containing zinc gluconate as the active ingredient. The company sells a focused portfolio of six SKUs across three product lines — Cold Shortening Lozenges (Natural Cherry, Honey Lemon soft-center, and Sugar-Free Wild Cherry), Plus Defense Lozenges (Manuka Honey & Lemon, Citrus with Elderberry), and Plus Cold & Flu Symptom Relief Lozenges (Mixed Berry). Its core efficacy claim — a 42% reduction in common cold duration when taken at first symptoms — is anchored in a Cleveland Clinic double-blind, placebo-controlled study published in the Annals of Internal Medicine. The proprietary zinc ion release technology is the technical backbone of the formulation, and a soft-center honey lozenge variant differentiates it on sensory experience in the lozenge category.

The company operates a dual go-to-market combining direct-to-consumer e-commerce on its Shopify-based coldeeze.com site with broad retail distribution across CVS, Walgreens, Rite-Aid, Walmart, Target, Kroger, and Amazon in the United States, plus an Amazon Canada storefront. Products are priced at $12.49–$12.99 per unit, with a Subscribe & Save subscription program offering a 15% discount on 1-, 2-, or 3-month cadences. Customer acquisition is supported by multi-channel digital marketing across Facebook, Instagram, TikTok, Pinterest, and YouTube, plus a content engine (MediFacts videos and health blog) and a healthcare-professional sampling program via DoctorSamples.com.

Cold-EEZE is a brand owned by Vespyr Brands, Inc., a privately held New Jersey corporation founded in 1996 with no disclosed funding history, no public listing, and no executive team information in the source material. Manufacturing is performed in FDA-registered facilities, and refunds are processed through WynnPharm Inc. in Freehold, NJ, indicating an outsourced manufacturing or distribution partner relationship. The company serves general consumers, health-conscious buyers seeking sugar-free options, and preventive-health consumers seeking immune support — a horizontally segmented audience rather than concentrated enterprise accounts.

Short descriptiontext

Cold-EEZE is a 30-year-old US consumer health brand that manufactures and markets homeopathic zinc-gluconate cold-shortening lozenges across three product lines, selling through national pharmacy and mass-retail chains, Amazon, and a Shopify DTC site to adult consumers seeking shorter cold duration.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersWindsor, United States
HQ citystring
Windsor
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cold shortening lozenges, zinc gluconate remedies, homeopathic cold treatment, OTC cold medicine, immune support supplements
Industry2 codes
PRIMARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIADAB
Cold, Flu & Cough Remedies
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
OTC Cold & Flu Remedies
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Product Sales
TypeOne Time License
Description

Cold-EEZE generates revenue through direct-to-consumer e-commerce sales on coldeeze.com and through retail distribution partnerships with major pharmacy and grocery chains. Products are sold as one-time purchases or through a Subscribe & Save program offering 15% discount for recurring subscriptions.

coldeeze.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Operations, Personnel, Others
Pricing details2 tiers
1Standard one-time purchase pricing for Cold Shortening Lozenges
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Most products priced at $12.99; Honey Lemon Soft-Center variant priced at $12.49

coldeeze.com
2Subscribe & Save subscription pricing
ModelSubscriptionBilling cadenceMonthly
Notes

Subscribe & Save offers 15% discount on all products with customizable delivery frequency (1, 2, or 3 month options)

coldeeze.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Cold-EEZE Plus Defense
Description

Product line that shortens cold duration and promotes immune health with additional ingredients like Echinacea and Rose Hips.

coldeeze.com
+1 more record
Core offering1 text field

Cold-EEZE manufactures and sells homeopathic cold-shortening lozenges formulated with zinc gluconate as the active ingredient. The portfolio includes core Cold Shortening Lozenges in Natural Cherry, Natural Liquid Honey Lemon (soft-center), and Sugar-Free Wild Cherry variants, plus tiered extensions such as Plus Defense Lozenges and Plus Cold & Flu Symptom Relief Lozenges that layer immune-supporting homeopathic actives. All products are clinically positioned to shorten common cold duration and are sold directly to consumers and through major retail pharmacies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 42% reduction in cold duration when taken at first sign of cold and used as directed
+2 more records
Product overview1 text field

Cold-EEZE is a homeopathic cold remedy brand marketed under Vespyr Brands, LLC. The product line consists of two tiers: (1) Core Cold Shortening Lozenges — available in Natural Cherry, Natural Liquid Honey Lemon (soft-center format), and Sugar-Free Wild Cherry variants — all containing zinc gluconate as the active ingredient, clinically proven to reduce common cold duration by 42% per Cleveland Clinic study; (2) Plus-tier products (Plus Defense and Plus Cold & Flu Symptom Relief) that layer homeopathic active ingredients (Echinacea, Rose Hips, Elderberry, Licorice Root, Oats) onto the zinc gluconate base to provide additional immune support and symptom relief. All products are available exclusively as lozenges.

Product and service1 record
1Cold Shortening Lozenges (Natural Cherry)
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1DoctorSamples.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Cold-EEZE partners with DoctorSamples.com to facilitate their free patient sample program, allowing healthcare providers to request sample kits of Cold-EEZE products for distribution to patients.

coldeeze.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cleveland Clinic conducted the pivotal double-blind placebo-controlled clinical study that validated Cold-EEZE's 42% reduction in cold duration claim. Study published in peer-reviewed Annals of Internal Medicine.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Zicam is the closest direct peer — also a zinc-based cold-shortening lozenge brand marketed for reducing cold duration, directly competing with Cold-EEZE on mechanism, format, and shelf placement in the same OTC 'cold shortening' subcategory.

TypeDirect peer
Description

Airborne sells immune-support gummies, lozenges, and tablets positioned similarly to Cold-EEZE's Plus Defense line, targeting the same preventive-health consumer segment with homeopathic-leaning claims.

3Halls
TypeBroad incumbent
Description

Halls (Mondelez) is the dominant mass-market cough drop brand, sharing Cold-EEZE's lozenge format and retail placement, but positioned around symptom relief (menthol) rather than cold duration reduction.

TypeDirect peer
Description

Ricola is a Swiss herbal lozenge brand selling cough and sore throat drops in the same retailers as Cold-EEZE, with comparable pricing and a natural-ingredient value proposition.

TypeDirect peer
Description

Zarbee's markets natural cough, cold, and immune syrups and lozenges targeted at adults and children, sharing Cold-EEZE's positioning around homeopathic and naturally-derived OTC remedies.

TypeBroad incumbent
Description

Mucinex is a broad cold/flu OTC medication brand owned by Reckitt, providing category-wide competition for cold symptom relief and immune support across multiple formats.

TypeDirect peer
Description

Fisherman's Friend is a heritage strong-menthol lozenge brand with comparable global distribution depth and a long-tenured consumer base for cold and sore throat relief.

TypeDirect peer
Description

Hyland's is a homeopathic OTC brand selling cold, cough, and immune products for adults and children, directly mirroring Cold-EEZE's homeopathic positioning and regulatory exposure.

TypeDirect peer
Description

Sambucol markets elderberry-based immune support products (lozenges, syrups, gummies) that overlap with Cold-EEZE's Plus Defense elderberry variants, competing for the same immune-support consumer.

TypeBroad incumbent
Description

Vicks is the largest cold/flu brand (P&G) with VapoRub, NyQuil, DayQuil, and cough drops, serving the same cold-and-flu consumer from a much wider portfolio and broader international distribution than Cold-EEZE.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cold-EEZE

OTC Cold & Flu Remediescoldeeze.com

Cold-EEZE is a 30-year-old US consumer health brand that manufactures and markets homeopathic zinc-gluconate cold-shortening lozenges across three product lines, selling through national pharmacy and mass-retail chains, Amazon, and a Shopify DTC site to adult consumers seeking shorter cold duration.

What Cold-EEZE does

Cold-EEZE is a US-based consumer health brand that manufactures and markets homeopathic cold-shortening lozenges containing zinc gluconate as the active ingredient. The company sells a focused portfolio of six SKUs across three product lines — Cold Shortening Lozenges (Natural Cherry, Honey Lemon soft-center, and Sugar-Free Wild Cherry), Plus Defense Lozenges (Manuka Honey & Lemon, Citrus with Elderberry), and Plus Cold & Flu Symptom Relief Lozenges (Mixed Berry). Its core efficacy claim — a 42% reduction in common cold duration when taken at first symptoms — is anchored in a Cleveland Clinic double-blind, placebo-controlled study published in the Annals of Internal Medicine. The proprietary zinc ion release technology is the technical backbone of the formulation, and a soft-center honey lozenge variant differentiates it on sensory experience in the lozenge category.

The company operates a dual go-to-market combining direct-to-consumer e-commerce on its Shopify-based coldeeze.com site with broad retail distribution across CVS, Walgreens, Rite-Aid, Walmart, Target, Kroger, and Amazon in the United States, plus an Amazon Canada storefront. Products are priced at $12.49–$12.99 per unit, with a Subscribe & Save subscription program offering a 15% discount on 1-, 2-, or 3-month cadences. Customer acquisition is supported by multi-channel digital marketing across Facebook, Instagram, TikTok, Pinterest, and YouTube, plus a content engine (MediFacts videos and health blog) and a healthcare-professional sampling program via DoctorSamples.com.

Cold-EEZE is a brand owned by Vespyr Brands, Inc., a privately held New Jersey corporation founded in 1996 with no disclosed funding history, no public listing, and no executive team information in the source material. Manufacturing is performed in FDA-registered facilities, and refunds are processed through WynnPharm Inc. in Freehold, NJ, indicating an outsourced manufacturing or distribution partner relationship. The company serves general consumers, health-conscious buyers seeking sugar-free options, and preventive-health consumers seeking immune support — a horizontally segmented audience rather than concentrated enterprise accounts.

Cold-EEZE firmographics

Firmographics
Name
Cold-EEZE
Legal name
Vespyr Brands, Inc.
Website
https://coldeeze.com
Company type
Private
Founded year
1996
Operating status
Operating
Short description
Cold-EEZE is a 30-year-old US consumer health brand that manufactures and markets homeopathic zinc-gluconate cold-shortening lozenges across three product lines, selling through national pharmacy and mass-retail chains, Amazon, and a Shopify DTC site to adult consumers seeking shorter cold duration.
Ownership category
akta.pro rank

Cold-EEZE industry classification

Industry
Product category
OTC Cold & Flu Remedies
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIADAB
Cold, Flu & Cough Remedies
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

  • Cold shortening lozenges
  • Zinc gluconate remedies
  • Homeopathic cold treatment
  • OTC cold medicine
  • Immune support supplements

Where Cold-EEZE is headquartered

Location

Headquarters

HQ city
Windsor
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cold-EEZE business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Operations, Personnel, Others

Revenue model

  1. Product Sales: Cold-EEZE generates revenue through direct-to-consumer e-commerce sales on coldeeze.com and through retail distribution partnerships with major pharmacy and grocery chains. Products are sold as one-time purchases or through a Subscribe & Save program offering 15% discount for recurring subscriptions.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard one-time purchase pricing for Cold Shortening Lozenges
SubscriptionMonthlySubscribe & Save subscription pricing

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Cold-EEZE product offering

Product offering

Core offering

Cold-EEZE manufactures and sells homeopathic cold-shortening lozenges formulated with zinc gluconate as the active ingredient. The portfolio includes core Cold Shortening Lozenges in Natural Cherry, Natural Liquid Honey Lemon (soft-center), and Sugar-Free Wild Cherry variants, plus tiered extensions such as Plus Defense Lozenges and Plus Cold & Flu Symptom Relief Lozenges that layer immune-supporting homeopathic actives. All products are clinically positioned to shorten common cold duration and are sold directly to consumers and through major retail pharmacies.

Product overview

Cold-EEZE is a homeopathic cold remedy brand marketed under Vespyr Brands, LLC. The product line consists of two tiers: (1) Core Cold Shortening Lozenges — available in Natural Cherry, Natural Liquid Honey Lemon (soft-center format), and Sugar-Free Wild Cherry variants — all containing zinc gluconate as the active ingredient, clinically proven to reduce common cold duration by 42% per Cleveland Clinic study; (2) Plus-tier products (Plus Defense and Plus Cold & Flu Symptom Relief) that layer homeopathic active ingredients (Echinacea, Rose Hips, Elderberry, Licorice Root, Oats) onto the zinc gluconate base to provide additional immune support and symptom relief. All products are available exclusively as lozenges.

Differentiator

Problem solved

Functional benefit

Brands

  • Cold-EEZE Plus Defense: Product line that shortens cold duration and promotes immune health with additional ingredients like Echinacea and Rose Hips.
  • Cold-EEZE Plus Cold & Flu

Products and services

  • Cold Shortening Lozenges (Natural Cherry)

Quantifiable outcome

  • 42% reduction in cold duration when taken at first sign of cold and used as directed
  • +2 more outcomes

Companies that use Cold-EEZE

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles4 records

Cold-EEZE technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Cold-EEZE partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor and core.

  • DoctorSamples.comminorChannel Partner/ Reseller/ DistributorCold-EEZE partners with DoctorSamples.com to facilitate their free patient sample program, allowing healthcare providers to request sample kits of Cold-EEZE products for distribution to patients.
  • Cleveland CliniccoreStrategic or Co-development PartnerCleveland Clinic conducted the pivotal double-blind placebo-controlled clinical study that validated Cold-EEZE's 42% reduction in cold duration claim. Study published in peer-reviewed Annals of Internal Medicine.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Cold-EEZE competitors and assessment

Company assessment

Direct peers

  • Zicam: Zicam is the closest direct peer — also a zinc-based cold-shortening lozenge brand marketed for reducing cold duration, directly competing with Cold-EEZE on mechanism, format, and shelf placement in the same OTC 'cold shortening' subcategory.
  • Airborne: Airborne sells immune-support gummies, lozenges, and tablets positioned similarly to Cold-EEZE's Plus Defense line, targeting the same preventive-health consumer segment with homeopathic-leaning claims.
  • Ricola: Ricola is a Swiss herbal lozenge brand selling cough and sore throat drops in the same retailers as Cold-EEZE, with comparable pricing and a natural-ingredient value proposition.
  • Zarbee's: Zarbee's markets natural cough, cold, and immune syrups and lozenges targeted at adults and children, sharing Cold-EEZE's positioning around homeopathic and naturally-derived OTC remedies.
  • Fisherman's Friend: Fisherman's Friend is a heritage strong-menthol lozenge brand with comparable global distribution depth and a long-tenured consumer base for cold and sore throat relief.
  • Hyland's: Hyland's is a homeopathic OTC brand selling cold, cough, and immune products for adults and children, directly mirroring Cold-EEZE's homeopathic positioning and regulatory exposure.
  • Sambucol: Sambucol markets elderberry-based immune support products (lozenges, syrups, gummies) that overlap with Cold-EEZE's Plus Defense elderberry variants, competing for the same immune-support consumer.

Broad incumbents

  • Halls: Halls (Mondelez) is the dominant mass-market cough drop brand, sharing Cold-EEZE's lozenge format and retail placement, but positioned around symptom relief (menthol) rather than cold duration reduction.
  • Mucinex (Reckitt Benckiser): Mucinex is a broad cold/flu OTC medication brand owned by Reckitt, providing category-wide competition for cold symptom relief and immune support across multiple formats.
  • Vicks (Procter & Gamble): Vicks is the largest cold/flu brand (P&G) with VapoRub, NyQuil, DayQuil, and cough drops, serving the same cold-and-flu consumer from a much wider portfolio and broader international distribution than Cold-EEZE.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Cold-EEZE social profiles

Digital presence

Cold-EEZE financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cold-EEZE leadership team

Management profile

Number of profiles

Profiles1 record

Cold-EEZE funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cold-EEZE M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cold-EEZE

What does Cold-EEZE do?

Cold-EEZE manufactures and sells homeopathic cold-shortening lozenges formulated with zinc gluconate as the active ingredient. The portfolio includes core Cold Shortening Lozenges in Natural Cherry, Natural Liquid Honey Lemon (soft-center), and Sugar-Free Wild Cherry variants, plus tiered extensions such as Plus Defense Lozenges and Plus Cold & Flu Symptom Relief Lozenges that layer immune-supporting homeopathic actives. All products are clinically positioned to shorten common cold duration and are sold directly to consumers and through major retail pharmacies.

Is Cold-EEZE a public or private company?

Cold-EEZE is a private company. It is classified as corporate owned and is currently operating.

When was Cold-EEZE founded?

Cold-EEZE was founded in 1996.

Where is Cold-EEZE based?

Cold-EEZE is headquartered in Windsor, United States, in the North America region.

How does Cold-EEZE make money?

One revenue line is on record: product Sales.

Who are Cold-EEZE's main competitors?

Direct peers on record are Zicam, Airborne, Ricola, Zarbee's, Fisherman's Friend, Hyland's and Sambucol. Broad incumbents are Halls, Mucinex (Reckitt Benckiser) and Vicks (Procter & Gamble).

Does Cold-EEZE have an API?

No public API is recorded for Cold-EEZE.

What industry is Cold-EEZE in?

Cold-EEZE's product category is OTC Cold & Flu Remedies. Its primary akta.pro industry code is CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges), with a secondary code of HLAIADAB, Cold, Flu & Cough Remedies. Its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals